HROW
Harrow, Inc. - Common Stock (HROW)
$11
About Harrow, Inc. - Common Stock (HROW)
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.
Details
Daily high
$29.73
Daily low
$28.86
Price at open
--
52 Week High
$54.85
52 Week Low
$27.00
Market cap
1.1B
Dividend yield
-
Volume
314
Avg. volume
643,430
P/E ratio
-29.37
Harrow, Inc. - Common Stock News
Details
Daily high
$29.73
Daily low
$28.86
Price at open
--
52 Week High
$54.85
52 Week Low
$27.00
Market cap
1.1B
Dividend yield
-
Volume
314
Avg. volume
643,430
P/E ratio
-29.37